Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets - Wikidata - wikimedia - TriplyDB

Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets

Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets

http://www.wikidata.org/entity/Q30374748

about

Interferon lambda: a new sword in cancer immunotherapy Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models Animal models for influenza virus pathogenesis, transmission, and immunology Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia Disease-promoting effects of type I interferons in viral, bacterial, and coinfections CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment.Pandemic influenza A (H1N1) virus infection and avian influenza A (H5N1) virus infection: a comparative analysis.Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice.Influenza A virus transmission: contributing factors and clinical implications.Newer influenza antivirals, biotherapeutics and combinations.Innate immune evasion strategies of influenza viruses Pathogenic potential of interferon αβ in acute influenza infection Oromucosal Administration of Interferon to Humans Influenza-induced production of interferon-alpha is defective in geriatric individuals.Memory B cells and CD8⁺ lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.Exogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of rhesus macaques Biodegradable nanogels for oral delivery of interferon for norovirus infection Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells.Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C.Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.Antitumor activity of type I and type III interferons in BNL hepatoma model Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection.The battle between influenza and the innate immune response in the human respiratory tract.Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.Oral delivery of oligomeric procyanidins in Apple Poly® enhances type I IFN responses in vivo.Influenza pharmacotherapy: present situation, strategies and hopes.Systems biology unravels interferon responses to respiratory virus infections.Productive replication and evolution of HIV-1 in ferret cells.The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond.Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression.The microbial metabolite desaminotyrosine protects from influenza through type I interferon.Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.Treating Influenza Infection, From Now and Into the Future

P2860

Q21296797-4B627D34-9713-4207-9290-CBB0AF27D663 Q24633851-9544C5F0-FDE6-4175-A36A-E9466FD74727 Q26740459-6A91FD58-2DB0-4920-AF2D-E6A5359040D6 Q27024582-33649B48-A316-4142-A913-1708160A85F9 Q27336255-0EC35F6A-04B7-400B-A37C-FA939ADC6AAF Q28082841-80D19FD1-0B61-4F4F-83BB-29C4FA7D8255 Q28741710-D23B6050-827D-4CB2-BB2E-2D8F94557251 Q28748500-2E70AD49-893D-4851-8A48-EEE2191AFDE9 Q30381638-A44285F8-797B-4247-8C10-11EA6E40320A Q30391696-94C3251A-8B33-4B75-AE46-FB67019C2628 Q30391956-0360EE08-983B-4C81-93E3-52FE7DCF414A Q30397203-ECA3BDDF-A15E-4F89-AC54-9A3D0A6F5E59 Q30456363-0756AB4B-EB97-4A62-83B2-00720A028130 Q33646273-EFD4931A-DD69-4E07-89B6-9C6B13C0ECE9 Q33663298-E3EBA79C-FE48-4592-85C2-371CC6A0D27F Q33663987-8AACB035-3CFB-4069-BB91-0350DEBB0984 Q33871391-3350BFBF-A0B8-4217-B2AB-8A9A5D5B39A5 Q33957968-DF7F0A65-6175-4872-9B1D-57BE3428F02E Q34119114-FC679059-08FA-4389-B65C-551F58AEDAF6 Q34525191-2BC35C1A-AD59-4984-9F0A-9493EB224C71 Q34602475-4D4DAF3C-4449-450A-9BDB-4353491E53A1 Q35905501-42F43A33-FD73-4912-8D10-6BCB832EC489 Q36263850-DB1270B3-FEBA-47A9-883A-D14009483183 Q36425910-A9CF1E6B-A5D1-4C9A-B973-506992DBED56 Q36559577-12A73A79-7C9D-40E9-8147-43115C45C973 Q36737913-BC65CF32-D41D-4AD0-B54F-72C16DEF736B Q37192137-D82085FB-6178-475F-8ADB-FE46C48D84B6 Q37678709-B0B143B6-30FB-4BAB-9586-1DFB04941A6A Q37700175-EA542695-66C2-4047-B011-FD2FFD8F94D2 Q37857854-A19EC177-40B4-4CB9-97F1-AF9BD70196DE Q38193816-43475A23-A476-47BA-91BF-9484227B397C Q38997444-D9C79DC1-7F6A-4C54-A70C-C03E0B64DF02 Q39223220-B6D2CB45-2D48-4835-B0AA-3FA89D43CE27 Q39406112-13C753B1-9E3B-4D2A-89FA-45A53543AC8C Q40107499-3C0C092D-C91D-4394-934B-CC1E9B9485B7 Q40357292-2D80B7D4-7F9F-4310-8392-EEE60ACA4789 Q40577440-79434881-0AA9-4670-812B-7E207089221D Q57158941-56EBF1AF-74CA-4C58-8D46-CFA5CFCEC0BB

P2860

Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets

http://www.wikidata.org/entity/Q30374748

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Intranasal administration of a ...... a A virus morbidity in ferrets

@ast

Intranasal administration of a ...... a A virus morbidity in ferrets

@en

type

label

Intranasal administration of a ...... a A virus morbidity in ferrets

@ast

Intranasal administration of a ...... a A virus morbidity in ferrets

@en

prefLabel

Intranasal administration of a ...... a A virus morbidity in ferrets

@ast

Intranasal administration of a ...... a A virus morbidity in ferrets

@en

P1433

Q30374748-43020F74-CA62-4B31-8061-405F26A90FA5

P1476

Q30374748-B395963A-9BCB-4AD1-87E5-E724B96A05CB

P2093

Q30374748-3525907F-3527-47A1-AB14-D0CA4860D7EE

Q30374748-6A6EB315-8805-448F-8498-BAC9B6A9CB53

Q30374748-79778BCB-CCA8-41A1-A01C-B887414A1037

Q30374748-C043E090-B2ED-47AE-B69D-0B88CC4C091E

Q30374748-CEB4F286-3865-4EC3-964A-8FA207B49646

Q30374748-FD03AA3A-32D5-4E26-B116-CA99008E52A2

P2860

Q30374748-0A4B2DE2-23AC-4BFC-BA54-51D1878B7827

Q30374748-0A80AD5B-0F28-4A02-B14A-EEEA0FC7BCCB

Q30374748-0BB14A72-3DDA-4E1D-8F1B-A58015CBBD9E

Q30374748-115F22FF-AEAA-4ABD-9A60-6600FDA16B9B

Q30374748-1835879E-D345-41E6-A0BF-03A501D43E04

Q30374748-183AC0D9-74E2-4415-B706-C6C5D9AF8A52

Q30374748-1A57C5C9-0871-46CB-A8EF-553758A16B44

Q30374748-21AF4F31-BB60-4BB0-8AC9-DAB19EC26472

Q30374748-2F740F0A-45FF-4EF0-9AB2-0FD9F3C5165A

Q30374748-31112DCC-A982-42BC-A9B2-F88532DAFBB5

P304

Q30374748-8B7EC38B-D933-49EF-9892-F16D61FFBD3F

P31

Q30374748-52847020-F157-41E8-898B-F0AF03FCD740

P356

Q30374748-94609DDE-E16A-4CF4-BB29-133AE7A13373

P433

Q30374748-4C0F0A93-F153-48BD-A536-19F7A117076B

P478

Q30374748-9FE64BCE-2F9F-479F-8ED6-F465BD680F81

P50

Q30374748-08DABFE7-F066-41BD-8EB6-B9B758ACD570

Q30374748-8626E533-F9BE-4112-902D-778FAE38D147

Q30374748-BC32CEA6-2CD1-471A-8081-E3C5D3767B82

P577

Q30374748-BDA1EDDF-77EE-4658-8BF1-B5A62BF8C0F3

P5875

Q30374748-78B1C930-FE87-4ECA-B917-9005C086A160

P698

Q30374748-1A9BF7B3-DF02-48C7-B718-FF082E1B9C15

P932

Q30374748-B2475546-40DF-489E-9C57-81FF2DBE144A

P356

P1433

Journal of Virology

P1476

Intranasal administration of a ...... a A virus morbidity in ferrets

@en

P2093

Daniela Kugel

http://www.w3.org/2001/XMLSchema#string

Georg Kochs

http://www.w3.org/2001/XMLSchema#string

Joachim Roth

http://www.w3.org/2001/XMLSchema#string

Otto Haller

http://www.w3.org/2001/XMLSchema#string

Peter Staeheli

http://www.w3.org/2001/XMLSchema#string

Veronika von Messling

http://www.w3.org/2001/XMLSchema#string

P2860

Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein

Interferon-inducible antiviral effectors

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

H5N1 Virus Attachment to Lower Respiratory Tract

Interferon-induced Mx proteins in antiviral host defense

Avian flu: influenza virus receptors in the human airway

Seasonal and pandemic influenza: a 2007 update on challenges and solutions.

Avian flu: isolation of drug-resistant H5N1 virus.

P304

3843-3851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02453-08

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Gary P. Kobinger

P577

2009-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23980265

http://www.w3.org/2001/XMLSchema#string

P698

19193792

http://www.w3.org/2001/XMLSchema#string

P932

2663257

http://www.w3.org/2001/XMLSchema#string